REGENXBIO Inc.RGNXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank25
3Y CAGR-29.2%
5Y CAGR-36.7%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-29.2%/yr
vs +6.4%/yr prior
5Y CAGR
-36.7%/yr
Recent acceleration
Acceleration
-35.6pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$34.47M-40.1%
2024$57.53M+66.6%
2023$34.52M-64.4%
2022$96.95M-71.9%
2021$345.21M+2.0%
2020$338.43M+386.8%
2019$69.51M-8.0%
2018$75.56M+62.0%
2017$46.66M+87.8%
2016$24.84M-